Combinatory Effect of Jerantinine A and Chemotherapeutic Agent in Regulating Spliceosome in Breast Cancer Stem Cells and Non-Stem Breast Cancer Cells

Abstract only Background: Breast cancer is the second most common cancer and is afflicting women globally. Current standard regimen of chemotherapy includes 2 main classes of drug anthracycline (e.g., doxorubicin) and taxane (e.g., paclitaxel). Two main issues are associated with these drugs: toxici...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of global oncology 2018-10, Vol.4 (Supplement 2), p.218-218s
Hauptverfasser: Tan, C.H., Mai, C.W., Leong, C.O.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!